Healthcare provider profile · identity verified

Saagar Patel, MD

Allopathic & Osteopathic Physicians|Family Medicine · IRVINGTON, KY · NPI 1770746794

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Saagar Patel, MD received $89.54 in general payments during 2025 across 5 reported records.

ABIOMED accounted for 34.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$89.54

5 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABIOMED	Unresolved — no canonical attribution shown	$30.53	34.1%	1	2025
Novartis Pharmaceuticals Corporation	Unresolved — no canonical attribution shown	$16.43	18.4%	1	2025
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$14.67	16.4%	1	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$14.08	15.7%	1	2025
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$13.83	15.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$89.54	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
LEQVIO Normalized: leqvio	Drug	Novartis Pharmaceuticals Corporation	$16.43	1	2025
Source payment records 2025-05-23 · Novartis Pharmaceuticals Corporation · $16.43 · Open Payments source
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$14.67	1	2025
Source payment records 2025-05-16 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $14.67 · Open Payments source
REPATHA Normalized: repatha	Biological	Amgen Inc.	$14.08	1	2025
Source payment records 2025-11-03 · Amgen Inc. · $14.08 · Open Payments source
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc.	$13.83	1	2025
Source payment records 2025-06-18 · Otsuka America Pharmaceutical, Inc. · $13.83 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	877	168
Furosemide	Furosemide	732	118
Amlodipine Besylate	Amlodipine Besylate	681	124
Lisinopril	Lisinopril	625	117
Pantoprazole Sodium	Pantoprazole Sodium	573	93
Levothyroxine Sodium	Levothyroxine Sodium	470	86
Omeprazole	Omeprazole	429	89
Trazodone Hcl	Trazodone Hcl	409	69
Metoprolol Succinate	Metoprolol Succinate	408	80
Potassium Chloride	Potassium Chloride	405	64
Gabapentin	Gabapentin	390	52
Metformin Hcl	Metformin Hcl	386	70
Rosuvastatin Calcium	Rosuvastatin Calcium	386	69
Eliquis	Apixaban	343	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	337	52
Tamsulosin Hcl	Tamsulosin Hcl	337	62
Losartan Potassium	Losartan Potassium	329	59
Escitalopram Oxalate	Escitalopram Oxalate	300	39
Sertraline Hcl	Sertraline Hcl	293	48
Simvastatin	Simvastatin	288	62
Alendronate Sodium	Alendronate Sodium	284	40
Buspirone Hcl	Buspirone Hcl	250	46
Donepezil Hcl	Donepezil Hcl	242	34
Hydrochlorothiazide	Hydrochlorothiazide	234	46
Tramadol Hcl	Tramadol Hcl	227	40
Clopidogrel	Clopidogrel Bisulfate	220	39
Citalopram Hbr	Citalopram Hydrobromide	217	38
Metoprolol Tartrate	Metoprolol Tartrate	204	37
Montelukast Sodium	Montelukast Sodium	194	29
Fluticasone Propionate	Fluticasone Propionate	191	45
Duloxetine Hcl	Duloxetine Hcl	187	25
Ropinirole Hcl	Ropinirole Hcl	185	25
Meloxicam	Meloxicam	184	40
Memantine Hcl	Memantine Hcl	184	27
Carvedilol	Carvedilol	169	27
Albuterol Sulfate Hfa	Albuterol Sulfate	165	59
Warfarin Sodium	Warfarin Sodium	156	15
Famotidine	Famotidine	152	21
Risperidone	Risperidone	151	18
Atenolol	Atenolol	149	21
Jardiance	Empagliflozin	149	22
Alprazolam	Alprazolam	146	28
Farxiga	Dapagliflozin Propanediol	145	22
Lorazepam	Lorazepam	138	23
Myrbetriq	Mirabegron	137	suppressed
Divalproex Sodium	Divalproex Sodium	135	18
Allopurinol	Allopurinol	133	27
Tradjenta	Linagliptin	130	14
Ozempic	Semaglutide	126	21
Xarelto	Rivaroxaban	121	suppressed
Azithromycin	Azithromycin	117	89
Isosorbide Mononitrate Er	Isosorbide Mononitrate	110	16
Fluoxetine Hcl	Fluoxetine Hcl	108	17
Januvia	Sitagliptin Phosphate	108	14
Prednisone	Prednisone	101	65
Fenofibrate	Fenofibrate Nanocrystallized	100	13
Glipizide	Glipizide	99	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	98	23
Baclofen	Baclofen	97	13
Cefdinir	Cefdinir	95	72
Hydralazine Hcl	Hydralazine Hcl	91	18
Bumetanide	Bumetanide	90	18
Finasteride	Finasteride	85	12
Glimepiride	Glimepiride	85	14
Amitriptyline Hcl	Amitriptyline Hcl	84	15
Pravastatin Sodium	Pravastatin Sodium	82	13
Clonazepam	Clonazepam	79	12
Ondansetron Hcl	Ondansetron Hcl	78	53
Ezetimibe	Ezetimibe	77	13
Lantus	Insulin Glargine,hum.Rec.Anlog	76	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	73	42
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	72	16
Spironolactone	Spironolactone	72	12
Clonidine Hcl	Clonidine Hcl	71	suppressed
Diclofenac Sodium	Diclofenac Sodium	70	22
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	70	41
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	68	suppressed
Fenofibrate	Fenofibrate,micronized	67	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	67	12
Paroxetine Hcl	Paroxetine Hcl	67	suppressed
Sucralfate	Sucralfate	65	12
Esomeprazole Magnesium	Esomeprazole Magnesium	64	13
Diazepam	Diazepam	63	suppressed
Loperamide	Loperamide Hcl	61	36
Quetiapine Fumarate	Quetiapine Fumarate	61	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	60	14
Ibuprofen	Ibuprofen	59	19
Amoxicillin	Amoxicillin	58	46
Aripiprazole	Aripiprazole	58	suppressed
Propranolol Hcl	Propranolol Hcl	58	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	56	suppressed
Bupropion Xl	Bupropion Hcl	54	suppressed
Levetiracetam	Levetiracetam	52	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	51	31
Digoxin	Digoxin	50	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	50	26
Nystatin	Nystatin	50	34
Fenofibrate	Fenofibrate	49	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	48	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	47	12
Linzess	Linaclotide	44	suppressed
Tizanidine Hcl	Tizanidine Hcl	44	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Celecoxib	Celecoxib	43	15
Repatha Sureclick	Evolocumab	43	suppressed
Doxepin Hcl	Doxepin Hcl	40	suppressed
Galantamine Hbr	Galantamine Hbr	40	suppressed
Prazosin Hcl	Prazosin Hcl	40	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	38	13
Pregabalin	Pregabalin	38	suppressed
Colestipol Hcl	Colestipol Hcl	36	suppressed
Latanoprost	Latanoprost	36	suppressed
Levemir	Insulin Detemir	36	suppressed
Cilostazol	Cilostazol	35	suppressed
Cyclosporine	Cyclosporine	35	suppressed
Diltiazem Hcl	Diltiazem Hcl	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	18
Incruse Ellipta	Umeclidinium Bromide	35	suppressed
Topiramate	Topiramate	35	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Nifedipine Er	Nifedipine	34	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Albuterol Sulfate	Albuterol Sulfate	32	13
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Memantine Hcl Er	Memantine Hcl	31	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Metformin Hcl Er	Metformin Hcl	30	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	30	suppressed
Humalog	Insulin Lispro	29	suppressed
Klor-Con M10	Potassium Chloride	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Ondansetron Odt	Ondansetron	29	18
Isosorbide Dinitrate	Isosorbide Dinitrate	28	suppressed
Naproxen	Naproxen	28	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Rybelsus	Semaglutide	27	suppressed
Ssd	Silver Sulfadiazine	27	suppressed
Budesonide	Budesonide	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	26	26
Lactulose	Lactulose	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Primidone	Primidone	25	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	13
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Indapamide	Indapamide	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Savella	Milnacipran Hcl	23	suppressed
Securesafe Pen Needle	Pen Needle, Diabetic, Safety	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Fluconazole	Fluconazole	21	14
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Sodium Chloride	0.9 % Sodium Chloride	21	15
Glipizide Er	Glipizide	20	suppressed
Insulin Lispro	Insulin Lispro	20	suppressed
Methylprednisolone	Methylprednisolone	20	17
Misoprostol	Misoprostol	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Amantadine	Amantadine Hcl	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	17	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Bethanechol Chloride	Bethanechol Chloride	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	16	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Metronidazole	Metronidazole	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Ropinirole Er	Ropinirole Hcl	16	suppressed
Torsemide	Torsemide	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Nateglinide	Nateglinide	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Dantrolene Sodium	Dantrolene Sodium	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Niacin Er	Niacin	13	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Prednisolone Acetate	Prednisolone Acetate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Moxifloxacin	Moxifloxacin Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Pramipexole Er	Pramipexole Di-Hcl	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tresiba	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$89.54 · 5 records	ABIOMED	CAPLYTA, LEQVIO, REPATHA, REXULTI	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error